Biochemical Reagent
-
BA6348 HG-14-10-04Summary: HG-14-10-04 is a potent mutation inhibitor. -
BA6349 YK-029ASummary: YK-029A is an orally effective mutation inhibitor.
-
BA6350 TAS0728Summary: TAS0728 is a potent, selective, orally active, irreversible covalent binding inhibitor of 13 nM.
-
BA6351 OritinibSummary: SH-1028 is an irreversible third-generation that overcomes T790M-mediated resistance in non-small cell lung cancer.
-
BA6352 PDZ1iSummary: PDZ1i is a potent, blood-brain barrier-crossing, specific inhibitor.
-
BA6353 EGFR-IN-70Summary: EGFR-IN-70 is a potent inhibitor.
-
BA6354 GW2974Summary: GW2974 is a potent dual inhibitor.
-
BA6356 PKI-166Summary: PKI-166 is a highly potent and selective, orally bioactive inhibitor.
-
BA6357 TheliatinibSummary: Theliatinib (Xiliertinib) is a potent, ATP-competitive, orally active and highly selective inhibitor.
-
BA6359 DBPR112Summary: DBPR112 is an orally effective fluoropyrimidine-based inhibitor.